Keeley Teton Advisors LLC Boosts Stock Position in Chemed Co. (NYSE:CHE)

Keeley Teton Advisors LLC boosted its stake in Chemed Co. (NYSE:CHE) by 9.2% during the fourth quarter, Holdings Channel.com reports. The fund owned 7,231 shares of the company’s stock after purchasing an additional 611 shares during the quarter. Keeley Teton Advisors LLC’s holdings in Chemed were worth $3,831,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in CHE. CIBC Asset Management Inc grew its position in shares of Chemed by 5.1% in the fourth quarter. CIBC Asset Management Inc now owns 457 shares of the company’s stock valued at $242,000 after purchasing an additional 22 shares during the period. CBIZ Investment Advisory Services LLC increased its stake in Chemed by 64.7% during the 4th quarter. CBIZ Investment Advisory Services LLC now owns 56 shares of the company’s stock worth $30,000 after buying an additional 22 shares in the last quarter. CIBC Private Wealth Group LLC raised its holdings in shares of Chemed by 13.5% during the fourth quarter. CIBC Private Wealth Group LLC now owns 185 shares of the company’s stock valued at $98,000 after acquiring an additional 22 shares during the last quarter. Independent Advisor Alliance boosted its stake in shares of Chemed by 1.1% in the fourth quarter. Independent Advisor Alliance now owns 2,279 shares of the company’s stock worth $1,207,000 after acquiring an additional 25 shares during the last quarter. Finally, EverSource Wealth Advisors LLC increased its position in shares of Chemed by 7.1% during the fourth quarter. EverSource Wealth Advisors LLC now owns 498 shares of the company’s stock worth $264,000 after purchasing an additional 33 shares in the last quarter. Hedge funds and other institutional investors own 95.85% of the company’s stock.

Chemed Stock Up 1.3 %

NYSE CHE opened at $600.87 on Tuesday. Chemed Co. has a 52 week low of $512.12 and a 52 week high of $625.09. The business’s fifty day simple moving average is $583.92 and its 200-day simple moving average is $567.73. The firm has a market cap of $8.78 billion, a PE ratio of 30.36, a P/E/G ratio of 2.15 and a beta of 0.49.

Chemed Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, March 14th. Shareholders of record on Monday, February 24th were issued a $0.50 dividend. The ex-dividend date of this dividend was Monday, February 24th. This represents a $2.00 annualized dividend and a yield of 0.33%. Chemed’s payout ratio is 10.05%.

Insider Activity

In other Chemed news, CEO Kevin J. Mcnamara sold 1,000 shares of Chemed stock in a transaction on Monday, March 31st. The stock was sold at an average price of $615.33, for a total value of $615,330.00. Following the sale, the chief executive officer now owns 101,679 shares in the company, valued at $62,566,139.07. The trade was a 0.97 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 3.32% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages have weighed in on CHE. Royal Bank of Canada raised their price objective on Chemed from $633.00 to $667.00 and gave the company an “outperform” rating in a report on Friday, March 14th. StockNews.com upgraded Chemed from a “hold” rating to a “buy” rating in a report on Friday, March 7th.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.